Femoston Continu

Femoston Continu is a hormone replacement therapy combining dydrogesterone and estradiol. It is designed to manage menopausal symptoms and support hormonal balance. This oral medication is manufactured by Abbott B.V. in the EU.

Femoston Continu is primarily used to alleviate menopausal symptoms such as hot flashes and vaginal dryness. It may also help prevent osteoporosis in postmenopausal women. This medication is often prescribed for women who have not had a hysterectomy and still have a uterus. The combination of dydrogesterone and estradiol aims to provide hormonal support and balance.

Common effects of Femoston Continu may include breast tenderness, headaches, and nausea. Some users might experience bloating or mood changes. These effects vary among individuals and typically subside as the body adjusts to the medication. Always consult a healthcare provider for personalized advice.

Femoston Continu should be used with caution in individuals with a history of blood clots, liver disease, or certain cancers. It is important to discuss your medical history with a healthcare provider before starting this medication. Regular monitoring may be recommended to ensure safety and effectiveness.

Femoston Continu may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. Alcohol consumption should be moderated, as it can affect the metabolism of hormones. Always inform your healthcare provider about all medications and supplements you are taking.